Mortality

Neurology

9 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
AMVUTTRA	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
exforge hct	Novartis AG (NVS)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
pravastatin	Aptinyx Inc. (APTX)
telmisartan	Inventiva S.A. (IVA)
valsartan	Mylan II B.V. (MYL)

Phase 3(1)

Drug	Company
Ceftriaxone 2g diluted in >200ml 0.9%sodium chloride	Valneva SE (VALN)

BioSniper tracks 9 drugs in development for Mortality across 9 companies.

There are 1 clinical trial targeting Mortality tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.